These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 5924958

  • 21. Combination chemotherapy involving alpha-difluoromethylornithine and 1-beta-D-arabinofuranosylcytosine in murine L1210 leukemia.
    Prakash NJ, Sunkara PS.
    Cancer Res; 1983 Jul; 43(7):3192-6. PubMed ID: 6406054
    [Abstract] [Full Text] [Related]

  • 22. Isolation and characterization of subclones of L1210 murine leukemia with different sensitivities to various cytotoxic agents.
    Brouwer M, Smets LA, Jongsma AP.
    Cancer Res; 1983 Jun; 43(6):2884-8. PubMed ID: 6850600
    [Abstract] [Full Text] [Related]

  • 23. Circadian optimization of the treatment of L1210 leukemia with 1-beta-D-arabinofuranosylcytosine, cyclophosphamide, vincristine and methylprednisolone.
    Burns ER, Scheving LE.
    Chronobiologia; 1980 Jun; 7(1):41-51. PubMed ID: 7438892
    [No Abstract] [Full Text] [Related]

  • 24. Metabolism and chemotherapeutic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia L1210 and evidence for its phosphorylation by deoxycytidine kinase.
    Brockman RW, Cheng YC, Schabel FM, Montgomery JA.
    Cancer Res; 1980 Oct; 40(10):3610-5. PubMed ID: 6254636
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of combination chemotherapy in vivo and in culture with l- -D-arabinofuranosylcytosine and 1-formylisoquinoline thiosemicarbazone.
    Grindey GB, Mihich E, Nichol CA.
    Cancer Res; 1972 Mar; 32(3):522-6. PubMed ID: 5061306
    [No Abstract] [Full Text] [Related]

  • 26. Uptake, initial effects, and chemotherapeutic efficacy of harringtonine in murine leukemic cells sensitive and resistant to vincristine and other chemotherapeutic agents.
    Chou TC, Schmid FA, Feinberg A, Philips FS, Han J.
    Cancer Res; 1983 Jul; 43(7):3074-9. PubMed ID: 6189591
    [Abstract] [Full Text] [Related]

  • 27. Cellular quantitation of in vivo effects of 1-beta-D-arabinofuranosylcytosine on leukemia L1210.
    Edelstein M, Valeriote F, Vietti T.
    J Natl Cancer Inst; 1977 Apr; 58(4):941-7. PubMed ID: 845997
    [Abstract] [Full Text] [Related]

  • 28. Effect of methotrexate and 1-beta-D-arabinofuranosylcytosine on pools of deoxyribonucleoside triphosphates in L1210 ascites cells.
    Roberts D, Peck C.
    Cancer Res; 1981 Feb; 41(2):505-10. PubMed ID: 7448798
    [Abstract] [Full Text] [Related]

  • 29. Biochemical and antitumor effects of the combination of thymidine and 1-beta-D-arabinofuranosylcytosine against leukemia L1210.
    Kinahan JJ, Kowal EP, Grindey GB.
    Cancer Res; 1981 Feb; 41(2):445-51. PubMed ID: 7448789
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Studies on the mode of action of 2,2'-anhydro-1- -D-arabinofuranosylcytosine.
    Wang MC, Sharma RA, Bloch A.
    Cancer Res; 1973 Jun; 33(6):1265-71. PubMed ID: 4578070
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Biochemical and cytokinetic modulation of L1210 and HL-60 cells by hydroxyurea and effect on 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity.
    Rauscher F, Cadman E.
    Cancer Res; 1983 Jun; 43(6):2688-93. PubMed ID: 6189585
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. DNA strand breaks caused by inhibitors of DNA synthesis: 1-beta-D-arabinofuranosylcytosine and aphidicolin.
    Fram RJ, Kufe DW.
    Cancer Res; 1982 Oct; 42(10):4050-3. PubMed ID: 6809309
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Paradoxical effect of cytosine arabinoside on mouse leukemia cell line L1210 cells.
    Nakayama T, Sakamoto S, Sassa S, Suzuki S, Kudo H, Nagasawa H.
    Anticancer Res; 2005 Oct; 25(1A):157-60. PubMed ID: 15816533
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.